This is part 2 of my interview with Dr Maha Hussain, Professor of Medical Oncology at the University
- Will Exelixis Cabozantinib COMET-1 prostate cancer trial be positive?
- Cabozantinib Mechanism of Action - Part 3 of an interview with Dr Maha Hussain
- Cabozantinib & Pain in Prostate Cancer - an interview with Dr Maha Hussain
- Prostate Cancer Session at AACR-NCI-EORTC Molecular Targets San Francisco
- ASCO 2011 Cabozantinib (XL184) may be an exciting new prostate cancer drug
- AUA 2011 New Prostate Cancer products in development beyond the androgen axis